Back to Results
First PageMeta Content
Keratoconus / Eye / Corrective lenses / Optometry / Bausch & Lomb / Refractive surgery / LASIK / Contact lens / Ectasia / Medicine / Ophthalmology / Eye surgery


SCORE Analyzer for the Objective Screening of Risk of Corneal Ectasia from Bausch + Lomb Technolas Receives CE Mark FOR RELEASE THURSDAY, APRIL 3, 2014 MUNICH, GERMANY — Bausch + Lomb, the global eye health company, an
Add to Reading List

Document Date: 2014-04-03 13:15:45

Open Document

File Size: 42,22 KB

Share Result on Facebook

City

MUNICH / Paris / /

Company

Bausch & Lomb Incorporated. / Bausch / Valeant Pharmaceuticals International Inc. / TECHNOLAS Perfect Vision GmbH / Lomb Company / /

Country

Germany / United States / /

IndustryTerm

patient / important new diagnostic tool / objective evaluation tool / ophthalmic pharmaceuticals / lens care products / software algorithm* / ophthalmic surgical devices / diagnostic tool / /

MedicalCondition

Subclinical Keratoconus / early stage keratoconus / significant keratoconus / keratoconus / /

MedicalTreatment

PRK surgery / surgery / LASIK / /

Organization

Rothschild Foundation / Gatinel D. Association of Corneal Indices for the Detection / European Union / /

Person

Damien Gatinel / Alain Saad / Kristian Hohla / /

Position

leader / Chairman / President / surgeon / /

Technology

laser / SCORE algorithm / *The algorithm / /

SocialTag